AGITG SPAR: A randomised placebo-controlled phase II trial of simvastatin in addition to neoadjuvant chemotherapy and radiation for rectal cancer

Category Primary study
Conference27th Annual Scientific Meeting of the Australasian Gastro-Intestinal Trials Group
Year 2025
This article has no abstract
Epistemonikos ID: ac3785a6311a897a81986e198193a15d46a7b316
First added on: Jan 10, 2026